Search Results 131-140 of 16617 for immunothérapie Bylaska
Participation eligibility · Chemotherapy ≤ 28 days prior to registration · Mitomycin C/nitrosoureas ≤ 42 days prior to registration · Immunotherapy ≤ 28 days ...
Treatment · Watch and wait · Chemotherapy · Immunotherapy · Radiation therapy · Targeted therapy · Clinical trials · CAR-T cell therapy · Bone marrow transplant.
... immunotherapy. Bladder Bank (a Prospective Banking Study). Rochester, Minn. The purpose of this study is to establish samples (blood and urine) to support ...
Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
... immunotherapy for patients who have stage IV metastatic melanoma. Evaluating Intestinal Microbiome and Immune Function in Lymphoma. Rochester, Minn. The ...
Such[...] Latest stories. Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your World Cancer Day gift can go 2X as far.